FDA Requires Fluoroquinolone Antibiotics To Better Warn Of Nerve Damage Risk

FDA Requires Fluoroquinolone Antibiotics To Better Warn Of Nerve Damage Risk

SILVER SPRING, Md. - The Food and Drug Administration said Aug. 15 that it has required the labels of oral fluoroquinolone antibiotic drugs to be updated to better describe the "serious side effect" of peripheral neuropathy.

Find full version on lexis Advance®
Access this news story on lexis.com®